Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Osterman, Mark T.
298  Ergebnisse:
Personensuche X
?
1

Su1791 DURABILITY OF RESPONSE IN DELAYED RESPONDERS TO OZAN..:

Regueiro, Miguel D. ; D'Haens, Geert ; Cross, Raymond K....
Gastroenterology.  166 (2024)  5 - p. S-815 , 2024
Link: https://doi.org/10.1016/..
 
?
2

ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dos..:

Jairath, Vipul ; Yarur, Andres ; Osterman, Mark T....
Clinical Gastroenterology and Hepatology.  22 (2024)  5 - p. 1077-1086.e13 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Su1766 OZANIMOD IS MORE EFFECTIVE IN ADVANCED THERAPY–NAIVE..:

Colombel, Jean Frederic ; Hanauer, Stephen B. ; Yarur, Andres...
Gastroenterology.  166 (2024)  5 - p. S-803-S-804 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Tu1889 REAL-WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD IN U..:

Lieto, Stephen ; Scalzo, Nicholas ; Huang, Katherine...
Gastroenterology.  166 (2024)  5 - p. S-1455-S-1456 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Ozanimod in Patients With Moderate to Severe Ulcerative Col..:

Sands, Bruce E. ; D'Haens, Geert ; Panaccione, Remo...
Clinical Gastroenterology and Hepatology.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Tu1742 ENDOSCOPIC, HISTOLOGIC, AND COMBINED OUTCOMES WITH R..:

Regueiro, Miguel D. ; Dignass, Axel ; Colombel, Jean Frederic...
Gastroenterology.  164 (2023)  6 - p. S-1105 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and Safety of Approximately 3 Years of Continuous ..:

Danese, Silvio ; Panaccione, Remo ; Abreu, Maria T...
Journal of Crohn's and Colitis.  18 (2023)  2 - p. 264-274 , 2023
Link: https://doi.org/10.1093/..
 
?
8

Tu1745 ACHIEVEMENT AND MAINTENANCE OF ENDOSCOPIC, HISTOLOGI..:

Chiorean, Michael V. ; Colombel, Jean Frederic ; Rubin, David T....
Gastroenterology.  164 (2023)  6 - p. S-1106-S-1107 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Tu1736 EXTENDED INDUCTION IN THE TRUE NORTH OPEN-LABEL EXTE..:

Rubin, David T. ; Colombel, Jean Frederic ; Chiorean, Michael V....
Gastroenterology.  164 (2023)  6 - p. S-1102 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Tu1450: EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDE..:

Panaccione, Remo ; Afzali, Anita ; Hudesman, David...
Gastroenterology.  162 (2022)  7 - p. S-965 , 2022
Link: https://doi.org/10.1016/..
 
?
11

791: A RANDOMIZED TRIAL OF VEDOLIZUMAB DOSE OPTIMIZATION IN..:

Osterman, Mark T. ; Jairath, Vipul ; Rana-Khan, Qasim...
Gastroenterology.  162 (2022)  7 - p. S-190-S-191 , 2022
Link: https://doi.org/10.1016/..
 
?
12

969: RECAPTURE OF RESPONSE WITH OZANIMOD IN PATIENTS WITH M..:

Afzali, Anita ; Chiorean, Michael V. ; Lawlor, Garrett...
Gastroenterology.  162 (2022)  7 - p. S-229 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Tu1472: RAPIDITY OF OZANIMOD-INDUCED SYMPTOMATIC RESPONSE A..:

Afzali, Anita ; Axelrad, Jordan E. ; Pondel, Marc...
Gastroenterology.  162 (2022)  7 - p. S-976 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Real‐world multicentre observational study including popula..:

Vande Casteele, Niels ; Sandborn, William J. ; Feagan, Brian G....
Alimentary Pharmacology & Therapeutics.  56 (2022)  3 - p. 463-476 , 2022
Link: https://doi.org/10.1111/..
 
?
15

The Impact of Introducing Patient-Reported Inflammatory Bow..:

Roy Paladhi, Unmesha ; Harb, Ali H ; Daniel, Scott G...
Inflammatory Bowel Diseases.  27 (2021)  5 - p. 746-750 , 2021
Link: https://doi.org/10.1093/..
 
1-15